Gene · 1317
Papers1,953
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,953
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SLC31A1 exon 1 methylation reduces intracellular copper ion and promotes diabetic cardiac fibrosis. | Cardiovasc Diabetol | 2026 | 41776560 | PubTator, text mining | PubMed |
| Ferroptosis and cuproptosis in head and neck squamous cell carcinoma: interconnected mechanisms and therapeutic implications. | Front Pharmacol | 2026 | 41769686 | PubTator, text mining | PubMed |
| Synergistic Toxicity of Cold Gas Plasma and Cisplatin in Bladder Cancer Cells. | Cancers (Basel) | 2026 | 41749928 | PubTator, text mining | PubMed |
| FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers. | Cell Death Dis | 2026 | 41714589 | PubTator, text mining | PubMed |
| D-ribose-induced cytotoxicity in K562 cells: RBKS-dependent disruption of copper homeostasis and mitochondrial function. | Free Radic Biol Med | 2026 | 41651301 | PubTator, text mining | PubMed |
| Distinct signaling mechanisms and proteome phenotypes are elicited by compartment-specific genetic defects of copper homeostasis. | bioRxiv | 2026 | 41648106 | PubTator, text mining | PubMed |
| Development and validation of a robust cuproptosis related signature for primary glioma via machine learning aided by loop training and validation. | Discov Oncol | 2026 | 41629670 | PubTator, text mining | PubMed |
| Cuproptosis promotes inflammatory osteolysis via GYS1-mediated glycogen metabolism. | Int J Oral Sci | 2026 | 41629272 | PubTator, text mining | PubMed |
| A C. elegans model of copper deficiency: Dietary interventions rescue CTR1/CHCA-1 copper transporter mutant phenotype. | PLoS Genet | 2026 | 41575937 | PubTator, text mining | PubMed |
| Innovative cross-intervention: copper ions and metabolic pathways in cancer therapy. | Cancer Biol Med | 2026 | 41560318 | PubTator, text mining | PubMed |
| ZNF384-regulated SLC31A1 expression promotes tumor proliferation and invasion in breast cancer. | Mol Cell Biochem | 2026 | 41553436 | PubTator, text mining | PubMed |
| Nanomedical approaches to deplete intracellular glutathione in oncology. | Chem Sci | 2026 | 41550570 | PubTator, text mining | PubMed |
| Rosmarinic Acid Is an hCtr1 Inhibitor that Interferes with Copper Transport Activity. | Inorg Chem | 2026 | 41494012 | PubTator, text mining | PubMed |
| YTHDC2 inhibits the resistance of lung cancer to EGFR-TKI through cuproptosis. | Oncogene | 2026 | 41402633 | PubTator, text mining | PubMed |
| Copper homeostasis and its dysregulation in diseases: A focus on cuproptosis. | Chem Biol Interact | 2026 | 41390135 | PubTator, text mining | PubMed |
| IL-17A-mediated copper accumulation participates in chronic neuropathic pain-induced cognitive impairment by enhancing microglial synaptic pruning. | Brain Behav Immun | 2026 | 41349925 | PubTator, text mining | PubMed |
| Novel Ce/Cu-modified black ceramics disrupted mitochondrial dysfunction and tricarboxylic acid cycle to induce cuproptosis in osteosarcoma cells. | Biomater Adv | 2026 | 41218466 | PubTator, text mining | PubMed |
| Copper transporter 1 contributes to the progression of cholangiocarcinoma. | Biochim Biophys Acta Gen Subj | 2026 | 41187846 | PubTator, text mining | PubMed |
| SIRT7 deficiency promoted cuproptosis-mediated mitochondrial dysfunction and inhibited malignant development of cervical cancer. | Arch Biochem Biophys | 2026 | 41167446 | PubTator, text mining | PubMed |
| Unveiling the Distinct Effects of a Two-Dimensional Copper/Sodium Complex: Oxidative Stress on Erythrocytes and Cytotoxicity, Apoptosis, Drug Resistance, and Inflammation in Lung Cancer Cells. | Anticancer Agents Med Chem | 2026 | 40916440 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1317/papers?page=4